Tredje AP fonden Sells 3,000 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Tredje AP fonden reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.5% during the fourth quarter, Holdings Channel reports. The firm owned 28,536 shares of the medical equipment provider’s stock after selling 3,000 shares during the period. Tredje AP fonden’s holdings in Intuitive Surgical were worth $14,895,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical during the fourth quarter worth about $26,000. BankPlus Trust Department purchased a new stake in Intuitive Surgical during the fourth quarter worth about $28,000. Kohmann Bosshard Financial Services LLC purchased a new stake in Intuitive Surgical during the fourth quarter worth about $31,000. MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical during the third quarter worth about $33,000. Finally, Decker Retirement Planning Inc. purchased a new stake in Intuitive Surgical during the fourth quarter worth about $36,000. 83.64% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts recently issued reports on ISRG shares. BTIG Research raised their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Jefferies Financial Group lifted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Wells Fargo & Company lifted their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. UBS Group lifted their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. Finally, Stifel Nicolaus lifted their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $497.30 on Thursday. The stock has a market cap of $177.13 billion, a price-to-earnings ratio of 77.58, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The firm has a 50-day moving average of $569.42 and a two-hundred day moving average of $531.60.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 22,209 shares of company stock valued at $11,928,127. Company insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.